| Brief report: dolutegravir plus abacavir/lamivudine for the treatment of HIV-1 infection in antiretroviral therapy-naive patients: week 96 and week 144 results from the SINGLE … S Walmsley, A Baumgarten, J Berenguer, F Felizarta, E Florence, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (5), 515-519, 2015 | 283 | 2015 |
| Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study E Florence, J Lundgren, C Dreezen, M Fisher, O Kirk, A Blaxhult, G Panos, ... HIV medicine 4 (3), 255-262, 2003 | 270 | 2003 |
| Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ... Clinical Infectious Diseases 56 (7), 1004-1017, 2013 | 222 | 2013 |
| HIV and syphilis: when to perform a lumbar puncture AÈ Libois, SÉ De Wit, BÉÉ Poll, F Garcia, E Florence, A Del Rio, ... Sexually transmitted diseases 34 (3), 141-144, 2007 | 208 | 2007 |
| Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection F García, M Lejeune, N Climent, C Gil, J Alcamí, V Morente, L Alós, A Ruiz, ... Journal of Infectious Diseases 191 (10), 1680-1685, 2005 | 195 | 2005 |
| Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment W Schrooten, R Colebunders, M Youle, G Molenberghs, N Dedes, G Koitz, ... Aids 15 (8), 1019-1023, 2001 | 157 | 2001 |
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 … A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ... Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015 | 142 | 2015 |
| Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors D Asboe, J Catalan, S Mandalia, N Dedes, E Florence, W Schrooten, ... AIDS care 19 (8), 955-965, 2007 | 121 | 2007 |
| mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients E Van Gulck, E Vlieghe, M Vekemans, VFI Van Tendeloo, A Van De Velde, ... Aids 26 (4), F1-F12, 2012 | 117 | 2012 |
| Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection AR Lifson, B Grund, EM Gardner, R Kaplan, E Denning, N Engen, ... Aids 31 (7), 953-963, 2017 | 96 | 2017 |
| Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen A Conesa-Botella, E Florence, L Lynen, R Colebunders, J Menten, ... AIDS research and therapy 7, 1-6, 2010 | 92 | 2010 |
| Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe E Florence, W Schrooten, C Dreezen, V Gordillo, LN Schönnesson, ... AIDS care 16 (5), 550-557, 2004 | 92 | 2004 |
| Antiretrovirals, fractures, and osteonecrosis in a large international HIV cohort ÁH Borges, J Hoy, E Florence, D Sedlacek, HJ Stellbrink, V Uzdaviniene, ... Clinical Infectious Diseases 64 (10), 1413-1421, 2017 | 88 | 2017 |
| Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001–2009 E Bottieau, L Apers, M Van Esbroeck, M Vandenbruaene, E Florence Eurosurveillance 15 (39), 2010 | 88 | 2010 |
| Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk JM Gatell, L Assoumou, G Moyle, L Waters, M Johnson, P Domingo, J Fox, ... Aids 31 (18), 2503-2514, 2017 | 87 | 2017 |
| Risk factors for HCV acquisition among HIV-positive MSM in Belgium L Apers, WV Berghe, S De Wit, K Kabeya, S Callens, J Buyze, C Kenyon, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (5), 585-593, 2015 | 79 | 2015 |
| Lipid levels and changes in body fat distribution in treatment-naive, HIV-1–infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE Trials P Tebas, M Sension, J Arribas, D Duiculescu, E Florence, CC Hung, ... Clinical infectious diseases 59 (3), 425-434, 2014 | 65 | 2014 |
| Transcriptome analysis of monocyte-HIV interactions R Van den Bergh, E Florence, E Vlieghe, T Boonefaes, J Grooten, ... Retrovirology 7, 1-16, 2010 | 63 | 2010 |
| Syphilis reinfections pose problems for syphilis diagnosis in Antwerp, Belgium–1992 to 2012 C Kenyon, L Lynen, E Florence, S Caluwaerts, M Vandenbruaene, ... Eurosurveillance 19 (45), 20958, 2014 | 62 | 2014 |
| Rheumatological complications associated with the use of indinavir and other protease inhibitors E Florence, W Schrooten, K Verdonck, C Dreezen, R Colebunders Annals of the rheumatic diseases 61 (1), 82-84, 2002 | 60 | 2002 |
Chris KenyonInstitute of Tropical Medicine, AntwerpVerified email at itg.be
